染色内镜在MUTYH相关息肉病与家族性腺瘤性息肉病患者十二指肠监测中的作用
一项前瞻性研究在英國两家学术中心纳入51例MUTYH相关息肉病(MAP)和家族性腺瘤性息肉病(FAP)连续患者,评估染色内镜对十二指肠腺瘤检出、Spigelman分期的影响。结果显示染色内镜使MAP和FAP腺瘤检出数量均增至3倍,并显著提高Spigelman分期,MAP的Spigelman评分和总体腺瘤检出显著低于FAP。
要点
- 染色内镜使MAP和FAP患者十二指肠腺瘤检出数量均增至3倍。
- 染色内镜后MAP和FAP的Spigelman分期较普通内镜显著升高。
- MAP患者的Spigelman评分和总体腺瘤检出显著低于FAP患者。
核心结论
- 染色内镜使MAP和FAP患者十二指肠腺瘤诊断产出提高3倍,并导致Spigelman评分出现有临床意义的上调。
研究设计与样本
- 前瞻性研究,2011年至2014年在英国两家学术中心(University Hospital Llandough, Cardiff和St Mark's Hospital, London)纳入51例MAP和FAP连续患者,评估染色内镜对十二指肠评估的影响。
主要发现
- 染色内镜后腺瘤检出数量增至3倍,MAP组P = .013,FAP组P = .002,但未影响腺瘤大小。
- 染色内镜后MAP和FAP的Spigelman分期均较未喷洒染料的内镜显著升高。
- MAP患者的Spigelman评分和总体腺瘤检出显著低于FAP患者。
临床怎么用
- 原文结论未据此给出临床推荐。
局限性
- 原文指出需进一步研究以确定腺瘤检出改善对十二指肠息肉病管理和结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Duodenal polyposis and cancer have become a key issue for patients with familial adenomatous polyposis (FAP) and MUTYH-associated polyposis (MAP). Almost all patients with FAP will develop duodenal adenomas, and 5% will develop cancer. The incidence of duodenal adenomas in MAP appears to be lower than in FAP, but the limited available data suggest a comparable increase in the relative risk and lifetime risk of duodenal cancer. Current surveillance recommendations, however, are the same for FAP and MAP, using the Spigelman score (incorporating polyp number, size, dysplasia, and histology) for risk stratification and determination of surveillance intervals. Previous studies have demonstrated a benefit of enhanced detection rates of adenomas by use of chromoendoscopy both in sporadic colorectal disease and in groups at high risk of colorectal cancer. We aimed to assess the effect of chromoendoscopy on duodenal adenoma detection, to determine the impact on Spigelman stage and to compare this in individuals with known pathogenic mutations in order to determine the difference in duodenal involvement between MAP and FAP. METHODS: A prospective study examined the impact of chromoendoscopy on the assessment of the duodenum in 51 consecutive patients with MAP and FAP in 2 academic centers in the United Kingdom (University Hospital Llandough, Cardiff, and St Mark's Hospital, London) from 2011 to 2014. RESULTS: Enhanced adenoma detection of 3 times the number of adenomas after chromoendoscopy was demonstrated in both MAP (P = .013) and FAP (P = .002), but did not affect adenoma size. In both conditions, there was a significant increase in Spigelman stage after chromoendoscopy compared with endoscopy without dye spray. Spigelman scores and overall adenoma detection was significantly lower in MAP compared with FAP. CONCLUSIONS: Chromoendoscopy improved the diagnostic yield of anomas in MAP and FAP 3-fold, and in both MAP and FAP this resulted in a clinically significant upstaging in Spigelman score. Further studies are required to determine the impact of improved adenoma detection on the management and outcome of duodenal polyposis.
引用
- Hurley JJ, Thomas LE, Walton SJ, et al. The impact of chromoendoscopy for surveillance of the duodenum in patients with MUTYH-associated polyposis and familial adenomatous polyposis. Gastrointest Endosc. 2018. PMID: 29702101. doi:10.1016/j.gie.2018.04.2347
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。